GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash and Bank | ₹1,063 Cr | ₹1,156 Cr | ₹2,485 Cr | ₹1,158 Cr | ₹1,083 Cr |
What is the latest Cash and Bank ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Cash and Bank |
---|---|
Mar2024 | ₹1,063 Cr |
Mar2023 | ₹1,156 Cr |
Mar2022 | ₹2,485 Cr |
Mar2021 | ₹1,158 Cr |
Mar2020 | ₹1,083 Cr |
How is Cash and Bank of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Cash and Bank | % Change | |
---|---|---|---|
Mar2024 | ₹1,063 Cr | -8.02 | |
Mar2023 | ₹1,156 Cr | -53.47 | |
Mar2022 | ₹2,485 Cr | 114.56 | |
Mar2021 | ₹1,158 Cr | 6.90 | |
Mar2020 | ₹1,083 Cr | - |
Compare Cash and Bank of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹37,976.1 Cr | -3.6% | -6.4% | 30.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -3.6% |
-6.4% |
30.5% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses